← SynDRA
NARLAPREVIR
SynDRA canonical compound SYN0024588 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Mechanism of action | HCV inhibitor |
Mechanisms of action (all sources)
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- SCH-900518
- SCH900518
- Arlansa
- (1R,2S,5S)-3-(N-(((1-((tert-butylsulfonyl)methyl)cyclohexyl)amino)carbonyl)-3-methyl-l- valyl)-N-((1s)-1-((cyclopropylamino)(oxo)acetyl)pentyl)-6,6-dimethyl-3- azabicyclo(3.1.0)hexane-2-carboxamide
- 2857LA2O07
- (1R,2S,5S)-N-((1S)-1-(2-(cyclopropylamino)-2-oxoacetyl)pentyl)-3-((2S)-2-(((1-(((1,1- dimethylethyl)sulfonyl)methyl)cyclohexyl)carbamoyl)amino)-3,3-dimethylbutanoyl)-6,6- dimethyl-3-azabicyclo(3.1.0)hexane-2-carboxamide
- 3-Azabicyclo(3.1.0)hexane-2-carboxamide, N-((1S)-1-(2-(cyclopropylamino)-2- oxoacetyl)pentyl)-3-((2s)-2-((((1-(((1,1-dimethylethyl)sulfonyl)methyl)cyclohexyl) amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-, (1R,2S,5S)-
- (1R,2S,5S)-3-[(2S)-2-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
- (1R,2S,5S)-3-[N-({1-[(tert-Butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
- Narlaprevir [USAN]
- Narlaprevir [USAN:INN]
- narlaprevirum
- UNII-2857LA2O07
- NARLAPREVIR [INN]
- Narlaprevir (USAN/INN)
- NARLAPREVIR [WHO-DD]
- SCHEMBL583183
- CHEMBL1255891
- GTPL11572
- TQP0852
- CHEBI:173104
- DTXSID801025746
- EX-A5389
- BDBM50537558
- ZINC68151111
- CS-0445
- NCGC00378650-01
- HY-10300
- D09644
- A916277
- Q27254268
- (1R,2S,5S)-3-((S)-2-(3-(1-((tert-butylsulfonyl)methyl)cyclohexyl)ureido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
- (1R,2S,5S)-3-{(2S)-2-[({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)amino]-3,3-dimethylbutanoyl}-N-[(3S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
- (1R,2S,5S)-N-[(3S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]-6,6-dimethyl-3-[3-methyl-N-({1-[(2-methylpropane-2-sulfonyl)methyl]cyclohexyl}carbamoyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide
- (1S,4S,5R)-3-[(2S)-2-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-3,3-dimethyl-butanoyl]-N-[(1S)-1-[2-(cyclopropylamino)-2-oxo-acetyl]pentyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-4-carboxamide
- (3S)-N-CYCLOPROPYL-3-{[(1R,2S,5S)-3-[(2S)-3,3-DIMETHYL-2-[({1-[(2-METHYLPROPANE-2-SULFONYL)METHYL]CYCLOHEXYL}CARBAMOYL)AMINO]BUTANOYL]-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXAN-2-YL]FORMAMIDO}-2-OXOHEPTANAMIDE
- RefChem:927513
- DTXCID001510010
Look up NARLAPREVIR in the interactive SynDRA portal →